FY07
Assets53.96
Net Worth9.09
Total Debt17.11
RevenueAnnualised basis38.61
EBITDAAnnualised basis1.19
PATAnnualised basis0.97
EBITDA Margin (%)3.08
At a glance
Updated 2026-09-27Bafna Pharmaceuticals is an IPO with an issue size of ₹25.60 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹25.60 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗PENDINGBidding has not started yet.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets59.86₹ Cr · +255.7% vs prior year
Net Worth11.91₹ Cr · +181.6% vs prior year
FY06
Assets21.39
Net Worth5.61
Total Debt11.46
RevenueAnnualised basis21.36
EBITDAAnnualised basis1.06
PATAnnualised basis0.85
EBITDA Margin (%)4.96
FY05
Assets16.83
Net Worth4.23
Total Debt6.78
RevenueAnnualised basis26.62
EBITDAAnnualised basis1.39
PATAnnualised basis0.89
EBITDA Margin (%)5.22
31-Dec-07
Assets59.86
Net Worth11.91
Total Debt24.09
RevenueAnnualised basis24.68
EBITDAAnnualised basis2.06
PATAnnualised basis1.29
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Bafna Pharmaceuticals IPO | — | 12.44 x | — | — |
| Symbiotec Pharmalab IPO | — | 61.88 x | — | — |
| Sai Parenteral's IPO | — | 111.58 x | — | — |
| Corona Remedies IPO | — | 35.15 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-27.
IPO UPDATE ALERTS
Register for IPO Updates →Track Bafna Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.